158 related articles for article (PubMed ID: 27344294)
1. Expression of STAT3 in Prostate Cancer Metastases.
Don-Doncow N; Marginean F; Coleman I; Nelson PS; Ehrnström R; Krzyzanowska A; Morrissey C; Hellsten R; Bjartell A
Eur Urol; 2017 Mar; 71(3):313-316. PubMed ID: 27344294
[TBL] [Abstract][Full Text] [Related]
2. Prostate stem cell antigen is overexpressed in prostate cancer metastases.
Lam JS; Yamashiro J; Shintaku IP; Vessella RL; Jenkins RB; Horvath S; Said JW; Reiter RE
Clin Cancer Res; 2005 Apr; 11(7):2591-6. PubMed ID: 15814638
[TBL] [Abstract][Full Text] [Related]
3. Epithelial mesenchymal-like transition occurs in a subset of cells in castration resistant prostate cancer bone metastases.
Haider M; Zhang X; Coleman I; Ericson N; True LD; Lam HM; Brown LG; Ketchanji M; Nghiem B; Lakely B; Coleman R; Montgomery B; Lange PH; Roudier M; Higano CS; Bielas JH; Nelson PS; Vessella RL; Morrissey C
Clin Exp Metastasis; 2016 Mar; 33(3):239-48. PubMed ID: 26667932
[TBL] [Abstract][Full Text] [Related]
4. Is computed tomography a necessary part of a metastatic evaluation for castration-resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital Database.
Hanyok BT; Howard LE; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Posadas EM; Freedland SJ
Cancer; 2016 Jan; 122(2):222-9. PubMed ID: 26484853
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of FAM84B during prostate cancer progression.
Wong N; Gu Y; Kapoor A; Lin X; Ojo D; Wei F; Yan J; de Melo J; Major P; Wood G; Aziz T; Cutz JC; Bonert M; Patterson AJ; Tang D
Oncotarget; 2017 Mar; 8(12):19218-19235. PubMed ID: 28186973
[TBL] [Abstract][Full Text] [Related]
6. JAK-STAT blockade inhibits tumor initiation and clonogenic recovery of prostate cancer stem-like cells.
Kroon P; Berry PA; Stower MJ; Rodrigues G; Mann VM; Simms M; Bhasin D; Chettiar S; Li C; Li PK; Maitland NJ; Collins AT
Cancer Res; 2013 Aug; 73(16):5288-98. PubMed ID: 23824741
[TBL] [Abstract][Full Text] [Related]
7. Osteoblasts promote castration-resistant prostate cancer by altering intratumoral steroidogenesis.
Hagberg Thulin M; Nilsson ME; Thulin P; Céraline J; Ohlsson C; Damber JE; Welén K
Mol Cell Endocrinol; 2016 Feb; 422():182-191. PubMed ID: 26586211
[TBL] [Abstract][Full Text] [Related]
8. In Men with Castration-Resistant Prostate Cancer, Visceral Metastases Predict Shorter Overall Survival: What Predicts Visceral Metastases? Results from the SEARCH Database.
Whitney CA; Howard LE; Posadas EM; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Freedland SJ
Eur Urol Focus; 2017 Oct; 3(4-5):480-486. PubMed ID: 28753787
[TBL] [Abstract][Full Text] [Related]
9. The analysis of serum response factor expression in bone and soft tissue prostate cancer metastases.
O'Hurley G; Prencipe M; Lundon D; O'Neill A; Boyce S; O'Grady A; Gallagher WM; Morrissey C; Kay EW; Watson RW
Prostate; 2014 Feb; 74(3):306-13. PubMed ID: 24249383
[TBL] [Abstract][Full Text] [Related]
10. Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer.
Beltran H; Prandi D; Mosquera JM; Benelli M; Puca L; Cyrta J; Marotz C; Giannopoulou E; Chakravarthi BV; Varambally S; Tomlins SA; Nanus DM; Tagawa ST; Van Allen EM; Elemento O; Sboner A; Garraway LA; Rubin MA; Demichelis F
Nat Med; 2016 Mar; 22(3):298-305. PubMed ID: 26855148
[TBL] [Abstract][Full Text] [Related]
11. Targeted Next-Generation Sequencing Reveals Heterogenous Genomic Features in Viscerally Metastatic Prostate Cancer.
Gong Y; Fan L; Fei X; Zhu Y; Du X; He Y; Pan J; Dong B; Xue W
J Urol; 2021 Aug; 206(2):279-288. PubMed ID: 33780283
[TBL] [Abstract][Full Text] [Related]
12. Docetaxel-mediated autophagy promotes chemoresistance in castration-resistant prostate cancer cells by inhibiting STAT3.
Hu F; Zhao Y; Yu Y; Fang JM; Cui R; Liu ZQ; Guo XL; Xu Q
Cancer Lett; 2018 Mar; 416():24-30. PubMed ID: 29246644
[TBL] [Abstract][Full Text] [Related]
13. MET expression during prostate cancer progression.
Verhoef EI; Kolijn K; De Herdt MJ; van der Steen B; Hoogland AM; Sleddens HF; Looijenga LH; van Leenders GJ
Oncotarget; 2016 May; 7(21):31029-36. PubMed ID: 27105539
[TBL] [Abstract][Full Text] [Related]
14. High levels of the AR-V7 Splice Variant and Co-Amplification of the Golgi Protein Coding YIPF6 in AR Amplified Prostate Cancer Bone Metastases.
Djusberg E; Jernberg E; Thysell E; Golovleva I; Lundberg P; Crnalic S; Widmark A; Bergh A; Brattsand M; Wikström P
Prostate; 2017 May; 77(6):625-638. PubMed ID: 28144969
[TBL] [Abstract][Full Text] [Related]
15. Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancer.
Roudier MP; Winters BR; Coleman I; Lam HM; Zhang X; Coleman R; Chéry L; True LD; Higano CS; Montgomery B; Lange PH; Snyder LA; Srivastava S; Corey E; Vessella RL; Nelson PS; Üren A; Morrissey C
Prostate; 2016 Jun; 76(9):810-22. PubMed ID: 26990456
[TBL] [Abstract][Full Text] [Related]
16. Expression of the gastrin-releasing peptide receptor, the prostate stem cell antigen and the prostate-specific membrane antigen in lymph node and bone metastases of prostate cancer.
Ananias HJ; van den Heuvel MC; Helfrich W; de Jong IJ
Prostate; 2009 Jul; 69(10):1101-8. PubMed ID: 19343734
[TBL] [Abstract][Full Text] [Related]
17. Estrogen related receptor alpha in castration-resistant prostate cancer cells promotes tumor progression in bone.
Fradet A; Bouchet M; Delliaux C; Gervais M; Kan C; Benetollo C; Pantano F; Vargas G; Bouazza L; Croset M; Bala Y; Leroy X; Rosol TJ; Rieusset J; Bellahcène A; Castronovo V; Aubin JE; Clézardin P; Duterque-Coquillaud M; Bonnelye E
Oncotarget; 2016 Nov; 7(47):77071-77086. PubMed ID: 27776343
[TBL] [Abstract][Full Text] [Related]
18. STAT3 phosphorylation is required for the HepaCAM-mediated inhibition of castration-resistant prostate cancer cell viability and metastasis.
Tan B; Chen X; Fan Y; Yang Y; Yang J; Tan L
Prostate; 2021 Jun; 81(9):603-611. PubMed ID: 33909312
[TBL] [Abstract][Full Text] [Related]
19. STAT3 is associated with lymph node metastasis in gastric cancer.
Deng J; Liang H; Zhang R; Sun D; Pan Y; Liu Y; Zhang L; Hao X
Tumour Biol; 2013 Oct; 34(5):2791-800. PubMed ID: 23824569
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of STAT3 prevents bone metastatic progression of prostate cancer in vivo.
Thulin MH; Määttä J; Linder A; Sterbova S; Ohlsson C; Damber JE; Widmark A; Persson E
Prostate; 2021 Jun; 81(8):452-462. PubMed ID: 33822400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
